Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

SUM-IAP compound MeSH Supplementary Concept Data 2025


MeSH Supplementary
SUM-IAP compound
Unique ID
C000614457
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000614457
Entry Term(s)
2-(2-((((2-chloroethyl)amino)((2-((methylsulfonyl)oxy)ethyl)amino)phosphoryl)oxy)ethyl)-1,3-thiazinane-4-carboxylic acid
N-(2-chloroethyl)-N'-(methanesulfonylethyl)phosphorodiamide-2-(2'-(4'-carboxy-1',3'-perhydrothiazinyl))ethyl ester
Registry Numbers
0
Heading Mapped to
*Organophosphorus Compounds
*Thiazines
Frequency
2
Note
has antineoplastic activity; structure in first source
Source
J Cancer Res Clin Oncol. 2016 Jun;142(6):1183-9.
Date of Entry
2017/02/23
Revision Date
2019/05/08
SUM-IAP compound Preferred
2-(2-((((2-chloroethyl)amino)((2-((methylsulfonyl)oxy)ethyl)amino)phosphoryl)oxy)ethyl)-1,3-thiazinane-4-carboxylic acid Broader
page delivered in 0.003s